| License: Creative Commons Attribution 4.0 PDF - Published Version (12MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-493160
- DOI to cite this document:
- 10.5283/epub.49316
Abstract
Background Patients with unresectable metastasized osteosarcoma have a poor prognosis. Current treatment options do not offer a chance to cure the disease in this situation. Despite the fact that immunotherapy has expanded its indications continuously over previous years, its use is not yet established in osteosarcoma. There is a lack of randomized controlled studies that could show a significant ...

Owner only: item control page